Improving how vasopressors are given to patients with early sepsis
Optimizing Vasopressor Delivery in Early Sepsis
This study is looking at how hospitals give important medications called vasopressors to people with severe sepsis and septic shock, to find the best ways to use them and help patients recover better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10996104 on NIH RePORTER |
What this research studies
This research focuses on optimizing the delivery of vasopressors, which are critical medications used to treat severe sepsis and septic shock. The project aims to understand the variations in how these medications are administered in hospitals and how these differences impact patient outcomes. By conducting advanced statistical analyses and randomized surveys, the research will gather data to inform best practices for vasopressor delivery. This work is essential for developing clinical trials that could lead to improved survival rates for sepsis patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with severe sepsis or septic shock who require vasopressor treatment.
Not a fit: Patients with mild infections or those not requiring vasopressor therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment protocols for sepsis, ultimately improving survival rates and recovery for patients.
How similar studies have performed: Previous research has shown that optimizing medication delivery methods can significantly improve patient outcomes, suggesting a strong potential for success in this area.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Munroe, Elizabeth — University of Michigan at Ann Arbor
- Study coordinator: Munroe, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.